Scientific article
Open access

Dernières recommandations européennes sur les dyslipidémies

Other titleA practitioner's perspective of the latest lipid guidelines
Published inRevue médicale suisse, vol. 18, no. 797, p. 1802-1805
Publication date2022-09-28

The latest ESC recommendations propose several interesting new concepts for the practitioner. The recommendations distinguish between the «apparently healthy» patient and the patient at specific cardiovascular risk (diabetes, renal failure, and familial hypercholesterolemia). New risk calculation tools are proposed (SCORE2 and SCORE2-OP). The proposed LDL-C targets are specific to each group, as a general rule, < 1.8 mmol/l for individuals at high risk and < 1.4 mmol/l for individuals at very high risk. Presence of risk modifiers, comorbidities and patient preferences modulates therapeutic approach which is usually based on optimizing lifestyle and statin medication when necessary.

  • Dyslipidémie
  • Risque cardiovasculaire
  • Recommandations
  • Anticholesteremic Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / prevention & control
  • Cholesterol, LDL
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipoproteinemia Type II
  • Life Style
  • Risk Factors
Citation (ISO format)
PONET, Loic et al. Dernières recommandations européennes sur les dyslipidémies. In: Revue médicale suisse, 2022, vol. 18, n° 797, p. 1802–1805. doi: 10.53738/REVMED.2022.18.797.1802
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/06/2022 2:05:41 PM
First validation05/17/2023 9:04:48 AM
Update time05/17/2023 9:04:48 AM
Status update05/17/2023 9:04:48 AM
Last indexation04/05/2024 2:17:15 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack